valproic acid and pramipexole

valproic acid has been researched along with pramipexole in 8 studies

Research

Studies (8)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	4 (50.00)	29.6817
2010's	4 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Andricopulo, AD; Moda, TL; Montanari, CA	1
Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Charney, DS; Denicoff, KD; Luckenbaugh, DA; Manji, HK; Payne, JL; Quiroz, JA; Singh, J; Zarate, CA	1
Friedrich, MJ	1
Hobara, N; Hokama, N; Kameya, H; Ohshiro, S; Uno, T	1
Coburn, KL; Doonan, SM; Lauterbach, EC; Mendez, MF; Shillcutt, SD; Victoroff, J	1
Junewar, V; Rathaur, BP; Verma, R	1

Reviews

2 review(s) available for valproic acid and pramipexole

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016
Psychopharmacological neuroprotection in neurodegenerative disease: assessing the preclinical data. The Journal of neuropsychiatry and clinical neurosciences, 2010,Winter, Volume: 22, Issue:1 Topics: Alzheimer Disease; Amyloid beta-Peptides; Antioxidants; Antipsychotic Agents; Benzodiazepines; Benzothiazoles; Brain; Clonazepam; Desipramine; Dibenzothiazepines; Dopamine Agonists; Humans; Lithium Carbonate; Maprotiline; Melatonin; Neurodegenerative Diseases; Neuroprotective Agents; Olanzapine; Parkinson Disease; Pramipexole; Quetiapine Fumarate; Selective Serotonin Reuptake Inhibitors; Valproic Acid	2010

Article

Year

DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.

Drug discovery today, 2016, Volume: 21, Issue:4

Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Psychopharmacological neuroprotection in neurodegenerative disease: assessing the preclinical data.

The Journal of neuropsychiatry and clinical neurosciences, 2010,Winter, Volume: 22, Issue:1

Topics: Alzheimer Disease; Amyloid beta-Peptides; Antioxidants; Antipsychotic Agents; Benzodiazepines; Benzothiazoles; Brain; Clonazepam; Desipramine; Dibenzothiazepines; Dopamine Agonists; Humans; Lithium Carbonate; Maprotiline; Melatonin; Neurodegenerative Diseases; Neuroprotective Agents; Olanzapine; Parkinson Disease; Pramipexole; Quetiapine Fumarate; Selective Serotonin Reuptake Inhibitors; Valproic Acid

2010

Trials

1 trial(s) available for valproic acid and pramipexole

Article	Year
Pramipexole for bipolar II depression: a placebo-controlled proof of concept study. Biological psychiatry, 2004, Jul-01, Volume: 56, Issue:1 Topics: Adult; Antidepressive Agents; Antimanic Agents; Benzothiazoles; Bipolar Disorder; Dopamine Agonists; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Lithium; Male; Middle Aged; Nerve Growth Factors; Pilot Projects; Pramipexole; Receptors, Dopamine D2; Receptors, Dopamine D3; Thiazoles; Valproic Acid	2004

Article

Year

Pramipexole for bipolar II depression: a placebo-controlled proof of concept study.

Biological psychiatry, 2004, Jul-01, Volume: 56, Issue:1

Topics: Adult; Antidepressive Agents; Antimanic Agents; Benzothiazoles; Bipolar Disorder; Dopamine Agonists; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Lithium; Male; Middle Aged; Nerve Growth Factors; Pilot Projects; Pramipexole; Receptors, Dopamine D2; Receptors, Dopamine D3; Thiazoles; Valproic Acid

2004

Other Studies

5 other study(ies) available for valproic acid and pramipexole

Article	Year
Hologram QSAR model for the prediction of human oral bioavailability. Bioorganic & medicinal chemistry, 2007, Dec-15, Volume: 15, Issue:24 Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship	2007
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate. Bioorganic & medicinal chemistry letters, 2010, Dec-15, Volume: 20, Issue:24 Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility	2010
Molecular studies probe bipolar disorder. JAMA, 2005, Feb-02, Volume: 293, Issue:5 Topics: Animals; Benzothiazoles; Bipolar Disorder; Carrier Proteins; Central Nervous System Agents; DNA-Binding Proteins; Gene Expression Regulation; Genes, bcl-2; Humans; Lithium Carbonate; Neuronal Plasticity; Pramipexole; Signal Transduction; Thiazoles; Transcription Factors; Valproic Acid	2005
Effects of a dopamine receptor agonist and atropine sulfate on absorption of valproic acid in rats. Biomedical research (Tokyo, Japan), 2009, Volume: 30, Issue:2 Topics: Administration, Oral; Animals; Atropine; Benzothiazoles; Dopamine Agonists; GABA Agents; Gastrointestinal Motility; Intestinal Absorption; Male; Muscarinic Antagonists; Pramipexole; Rats; Rats, Sprague-Dawley; ROC Curve; Valproic Acid	2009
An atypical case of neuroleptic malignant syndrome precipitated by valproate. BMJ case reports, 2014, Mar-06, Volume: 2014 Topics: Anticonvulsants; Antipsychotic Agents; Benzodiazepines; Benzothiazoles; Dopamine Agonists; Drug Therapy, Combination; Female; Fluid Therapy; Humans; Levetiracetam; Lorazepam; Middle Aged; Neuroleptic Malignant Syndrome; Olanzapine; Piracetam; Pramipexole; Psychotic Disorders; Valproic Acid	2014